US set records for COVID-19 cases, hospitalizations and deaths Wednesday

ByChristina Maxouris, CNN
Thursday, December 17, 2020
US COVID cases, hospitalizations, deaths break records Wednesday
"Good Morning America" has an exclusive look inside one of the hardest-hit hospitals in the nation amid the coronavirus pandemic.

NEW YORK -- The US on Wednesday reported record numbers for COVID-19 cases, hospitalizations and deaths, ahead of a key meeting for what could be the country's second COVID-19 vaccine to get the green light.

Vaccine advisers to the Food and Drug Administration will meet Thursday to discuss Moderna's vaccine and officials expect a speedy emergency use authorization process -- even faster than last week's for the Pfizer vaccine.

Hundreds of American health care workers have received their first dose of the Pfizer vaccine and many states have announced they're also expecting nursing home resident vaccinations to begin this week. And on Wednesday, the FDA said people administering that vaccine may squeeze out extra doses from the vials if there is leftover solution in them after giving the standard five doses.

Another vaccine could be on the way to protect those most vulnerable to COVID-19.

Politico was first to report that some pharmacists found they could get six -- and possibly even seven -- doses of vaccine out of vials, which are each designed to provide five doses of vaccine. An FDA spokeswoman told CNN the agency was aware of the issue and "working with Pfizer to determine the best path forward."

"At this time, given the public health emergency, FDA is advising that it is acceptable to use every full dose obtainable (the sixth, or possibly even a seventh) from each vial, pending resolution of the issue," the spokeswoman said. "However, since the vials are preservative-free, it is critical to note that any further remaining product that does not constitute a full dose should not be pooled from multiple vials to create one."

More than 2.9 million doses were allocated to states for the first Pfizer vaccine doses, according to a list published Wednesday by the Centers for Disease Control and Prevention. Another more than 2.9 million will be available for second doses about 21 days later.

The first vaccinations and a possible green light for Moderna are all good news. But the pandemic raging in the US is still far from over -- and more brutal than ever.

Wednesday saw grim numbers all across -- the highest COVID-19 infections and deaths ever reported in a single day, and the most COVID-19 hospitalizations the country has seen since the start of the pandemic.

More than 247,000 new cases were reported. More than 113,000 Americans are hospitalized with the virus, according to the COVID Tracking Project. And more than 3,600 deaths were added to the nation's death toll.

President-elect Joe Biden on Dec. 8 promised to distribute a coronavirus vaccine to 100 million people during the first three months of his incoming administration, pledging "100 million shots in the first 100 days." He also pledged to promote masking and get kids back to school.

'Still at a dangerous and critical' part in pandemic

While there's been some progress in slowing the spread of the virus in the northern and central US, according to the White House coronavirus task force, cases are still surging in more populated states.

"Stabilization in the Northern Plains, Upper Midwest, and some Rocky Mountain and Heartland states is being offset by significant deterioration in more populous states (82% of the population)," reports sent to states by the task force and obtained by CNN said.

And now, Americans have important choices to make: the upcoming holidays could help drive another surge of cases, hospitalizations and, inevitably, deaths, if people opt to travel and gather again. Despite a warning from the CDC before Thanksgiving urging against travel, more than four million spent the holiday away from home.

In California, where Los Angeles County health officials continue to report exploding case numbers, health services director Dr. Christina Ghaly attributed the surge to residents gathering over the Thanksgiving holiday despite repeated pleas to stay home.

And the worst is yet to come, Ghaly added, saying "we are still in for a very rough few weeks at least, and potentially through January."

Governors across the Northeast and Midwest issued a video message this week encouraging residents to "double down" on safety measures and reconsider their holiday plans.

"If you are planning to travel or gather with other households for the holidays -- we urge you to reconsider," the governors said. "Just one infection can cause an outbreak in your community, which could overwhelm our hospitals and put you and your loved ones at risk."

In hopes of helping curb the spread around the holidays, El Paso County Judge Ricardo Samaniego announced curfews from 10 p.m. to 5 a.m. lasting from December 23 to December 26 and from December 30 to January 4.

"What people need to know is, we are still at a dangerous and critical part of this pandemic, and tens of thousands of American lives are at stake," Adm. Brett Giroir, assistant secretary for health at the Department of Health and Human Services, said Wednesday.

"If you can avoid traveling, that's a good measure," he added.

More COVID-19 at home tests authorized

Meanwhile, the FDA also issued an emergency use authorization Wednesday for another at-home COVID-19 test -- this one for Abbott's BinaxNOW COVID-19 Ag Card Home Test.

The test is authorized for "prescription use at home with self-collected nasal swab samples from individuals ages 15 years or older who are suspected of COVID-19 by their health care provider within the first seven days of symptom onset," the agency said in a statement. Adults can take samples for younger children.

Abbott has said the new test will cost $25.

"FDA continues to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options," FDA Commissioner Stephen Hahn said in a statement.

That comes a day after the FDA also gave emergency use authorization to a $30 over-the-counter test made by Ellume that people can take home and give to themselves.

On Wednesday, Giroir said there will likely be more good news from the FDA soon about "other home tests that are not exactly the over-the-counter type but are in the same ballpark."

"You'll see more and more tests get authorized, and then ramping up very soon in the early part of the year," he added.

FDA investigating an allergic reaction to vaccine

The FDA is also investigating an allergic reaction suffered by an Alaska health care worker who doctors say got Pfizer's vaccine on Tuesday and felt flushed within 10 minutes, and later reported symptoms including shortness of breath and elevated heart rate.

The case is the first allergic reaction to the vaccine to be reported in the US -- but officials say they are expecting the occasional reaction and are prepared to treat anyone suffering from one.

The health care worker -- a middle-aged woman -- had no known history of severe allergic reaction to vaccines, her doctors said Wednesday.

"About one out of every million people that get a vaccine can have a severe allergic reaction to the vaccine," Dr. Paul Offit, a member of the FDA's vaccine advisory committee, told CNN. "What we need to find out is what specifically seems to be inducing this allergic reaction."

The case is something health officials need to look into, Offit said.

"Currently, the CDC recommendation is that if you ever had a severe allergic reaction to an injectable medical product, you shouldn't get this vaccine," he said. "If you have a history of severe allergic reactions, then what you should do is you get the vaccine, but you have to wait for 30 minutes in the area to make sure that you can get the shot of epinephrine that will make those symptoms go away.

"If you've never had a severe allergic reaction, you have to wait for 15 minutes for the same reason."

The-CNN-Wire & © 2020 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.